MakeO (formerly Smileneo), founded by Arpi Mehta in 2018, disrupts orthodontics with clear aligner solutions delivered directly to consumers. Based in Mumbai, MakeO leverages tele-orthodontics, 3D-printing, and AI-driven treatment planning to offer affordable, personalized aligners. Patients receive at-home scanning kits and follow up virtually, streamlining the traditional braces process and reducing clinic visits. In FY24, MakeO reported ₹260 Cr in revenue, transitioned to a ₹20 Cr net profit, and achieved a 12% EBITDA margin, while expanding its team to 140 employees and launching operations in Southeast Asia. Backed by Matrix Partners India and Peak XV, MakeO has raised $21 million to scale its tech platform, expand manufacturing capabilities, and invest in AI-driven treatment optimization. Its focus on patient experience and cost-effective care positions MakeO as a leader in the direct-to-consumer dental space.
Founding Year | 2018 |
---|---|
Headquarters | Mumbai, Maharashtra, India |
Valuation | ~$50 M (2023) |
Total Funding | $21 M |
Annual Revenue | ₹260 Cr (FY24) |
Annual Net Profit/Loss | ₹20 Cr (FY24) |
EBITDA Margin | 12% (FY24) |
Employees | ~140 (FY24) |
Round | Date | Amount | Investors |
---|---|---|---|
Seed | 2018 | $1M | Smileneo |
Series A | 2020 | $5M | Matrix Partners India |
Series B | 2022 | $15M | Peak XV Partners |
In 2025, MakeO launched a subscription-based clear aligner model, increasing customer retention by 25%.
Metric | Details |
---|---|
Revenue | ₹150 Cr → ₹200 Cr → ₹260 Cr |
Profit/Loss | ₹-10 Cr → ₹5 Cr → ₹20 Cr |
EBITDA Margin | -3% → 5% → 12% |
Employees | 100 → 120 → 140 |
Funding | $1 M → $5 M → $15 M |
IPO Status | Private; targeting public listing post scale. |
Expansion Focus | D2C APAC, AI, 3D-print scale. |
Latest News | Subscription model launch |
MakeO’s strong revenue growth, path to profitability, and customer-centric innovations affirm its leadership in the direct-to-consumer orthodontics market.
Make smarter business decisions with verified insights on companies and directors. Visit Affluense.ai to learn more.
Disclaimer: © 2025. All information is curated from public and third-party sources and provided solely for legitimate business use.